$0.985
+0.350 (+35.53%)Al cierre
Predicciones de precio
Ábrelo en la app para desbloquear previsiones a más largo plazo.
Predicción y previsión de ESLA por análisis de gráficos similares
Alphio's ESLA stock price prediction model matches the current Estrella Immunopharma Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $1.00 (+1.10%). The 1-week path is $1.00 (+1.75%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
¿Debería comprar acciones de Estrella Immunopharma Inc?
Estrella Immunopharma Inc (ESLA) is a good buy right now due to its recent price surge of 129.07% over the last five days, indicating strong momentum. The RSI is at 86.195, suggesting the stock is overbought but also reflects high investor interest. The company has activated a new clinical trial site, which could enhance its growth potential in the oncology sector. However, the main risk is its significant net losses, with a net income of -5,544,878 USD in Q2 2025, indicating ongoing financial challenges.
ESLA cerró en $0.99 el Friday, tras subir +35.53%
Estrella Immunopharma Inc (ESLA) last closed at $0.985, gaining +35.53%. These facts feed the 1-day and 1-week ESLA price prediction above.
Factores de la previsión
Los factores de la previsión de Estrella Immunopharma Inc (ESLA) combinan patrones gráficos similares, estacionalidad y medias móviles.
Similar patterns
Bullish
Seasonality
Bearish
SMA 20
Bullish
SMA 200
Bearish
Patrones gráficos similares
Acciones cuya trayectoria reciente más se parece a la de ESLA, ordenadas por similitud.
Análisis de estacionalidad de ESLA
Historically the probability of a positive October return for ESLA is 39.68%. December offers the highest probability of a positive month at 93.02%, while June is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
Proyecciones de precio a 10 años de ESLA
| Mes | Precio mínimo | Precio medio | Precio máximo | ROI potencial |
|---|---|---|---|---|
| Oct 2026 | $0.93 | $0.94 | $1.01 | -4.21% |
| Nov 2026 | $0.80 | $0.89 | $0.91 | -9.78% |
| Dec 2026 | $0.69 | $0.79 | $0.89 | -19.63% |
En 2026, se proyecta que Estrella Immunopharma Inc (ESLA) oscile entre $0.69 y $1.01.
Previsión mensual de Estrella Immunopharma Inc para 2026
En Oct de 2026, se proyecta que Estrella Immunopharma Inc promedie $0.94, con un mínimo de $0.93 y un máximo de $1.01.
En Nov de 2026, se proyecta que Estrella Immunopharma Inc promedie $0.89, con un mínimo de $0.80 y un máximo de $0.91.
En Dec de 2026, se proyecta que Estrella Immunopharma Inc promedie $0.79, con un mínimo de $0.69 y un máximo de $0.89.
Esta página es solo para investigación y no constituye asesoramiento de inversión. Los modelos pueden equivocarse. El rendimiento pasado no garantiza resultados futuros.